In the past 30 years, Chengda金道 International has developed from a如用 traditional textile and apparel tradin能地g company in做雨to a value-add文自ed trading ser木綠vice provide購唱r with R&D and design,農制 cutting-edge marketi來微ng, cross-border 女服sourcing and logistics services. The 個美company is headquartered in Dali哥能an and has wholly owned subsidi日北aries in Shanghai and Tokyo.
With more than 200 domestic and oversea看街s high-qualit技照y suppliers and direct marketing agenc坐麗ies in Southeast Asia 議些with Bangladesh as the procurement 雨票fulcrum, Chengda I些懂nternational has strong c風都ross-border procurement capability子月.
As a supply chain 理樹organizer and manager, w綠去e are committe理書d to building a globally competit睡河ive trade service provi事聽der with annual sales of nearl文科y RMB 2 billio見很n and long-term service customers in m錢體ore than 50 countries and re通兒gions, including Japan, North America行房, South America a來裡nd Europe.
The company 車中has 8 wholly-owned or holding明算 subsidiaries a南歌nd 5 shareholding compani鄉一es, mainly engaged in supply新從 chain (trade), medicin身聽e and medical c志道are, financial inve樂謝stment, energy developm門老ent, etc. The total annual profi訊拍t peaked at 2.3 billion yuan, and the哥章 market value of the stock peak老要ed at more than 60 billion yu用錢an.
Founded in Dal男數ian, China
Annual sales
Annual purchase v事輛olume
Business scope
Cotton and Woolen Pr冷志oducts Impor低化t & Export Corporation, 民這engaging in textile and garment imp服哥ort and export business.
the whole company was restructured into視請 a joint-stock company, and renamed a什他s Liaoning Chengda Co樹火mpany Limited with a registered cap吧員ital of 50 million yua東火n.
and on August 19, 1996, the comp北爸any was listed on the 人科Shanghai Stock制看 Exchange with the stock c小山ode 600739, and the registered capital厭一 was increased to 168 million麗商 yuan.
In January 1998, th請拍e company invested in Guangfa S對她ecurities Co., Ltd.
bio-pharmaceuticals, energy deve白現lopment and financial services 刀拿with the original accumulation of te河可xtile and garment trade for many year玩亮s.
was invested and established. Chengda 會刀Biological has become one of the most t熱內echnologically co我就mplete vaccine R&D and pr少線oduction companies in C南要hina, and is curren麗坐tly the world's lar線關gest human rabies vaccine manufact術區urer.
was established as a holding為時 subsidiary with a registered capital 習器of RMB 60 million on the basis of th微腦e original main busin民作ess of Liaoning Chengda 微子- import and export trade門現 of textile and garment銀跳s.
In 2013, Chengd市內a International intr拿火oduced the advanced medical去志 concept and produ子玩ction technology著鐵 from Japan 月見and entered into the medical and 小水health field, and establis司窗hed the brand of黃什 Tomomi-Chengda Zhimei.
was established. In Februa歌行ry 2015, Liaoning Chengda Internati飛年onal Co.
In 2018, Chengda In火白ternational integrat我那ed advanced technology from J紙路apan and R&D res服司ources from 地西domestic universities to ente很光r the field of new high-tech text還個ile materials and 答多established TecNature brand.
Supply
Medical
Financial
Energy